spec sheet8 rows
Testosterone undecanoate is a long-chain fatty acid ester of testosterone taken as an oral softgel; it is absorbed through intestinal lymphatics rather than the portal vein, which is what lets an oral androgen work at all.
- An oral testosterone that actually works, no injection needed
- Absorbed through intestinal lymphatics rather than the portal vein
- A genuinely clever way around first pass metabolism
- A long chain fatty acid ester of testosterone
- Softgel form, swallowed rather than injected
- Testosterone replacement that is indicated is worth having
- Testosterone undecanoate exists in two very different clinical forms: a long-acting intramuscular depot in castor oil (Nebido in Europe since 2003, Aveed FDA-approved 2014) dosed roughly every 10 to 14 weeks, and modern oral formulations (Jatenzo FDA-approved 2019, Tlando and Kyzatrex 2022) taken twice daily with food.
- The undecanoate ester is what makes oral testosterone possible: its lipophilicity routes absorption through intestinal lymphatics with dietary fat, bypassing the first-pass hepatic metabolism that destroys unmodified oral testosterone [2].
- T4DM, a 2-year phase 3b randomized trial of injectable testosterone undecanoate in 1,007 men, showed a reduction in the proportion developing type 2 diabetes beyond a lifestyle programme, but with treatment-limiting haematocrit increases and prespecified serious adverse events in 10.9% versus 7.4% on placebo [1].
- Oral TU reliably restores serum testosterone into the eugonadal range in hypogonadal men [2][3], and modern formulations do not carry the hepatotoxicity of the older 17-alpha-alkylated oral androgens [6].
- Injectable TU and testosterone enanthate performed comparably as gender-affirming therapy in trans males in a 2025 randomized comparison [4].
- The large TRAVERSE trial that found no excess of major adverse cardiac events with testosterone replacement used a transdermal gel, not undecanoate, so that reassurance does not transfer directly to this ester.
Mechanism
Plain testosterone taken by mouth is destroyed almost entirely by hepatic metabolism. Esterifying the 17-beta hydroxyl with undecanoic acid makes the molecule enough to partition into chylomicrons and enter the lymphatic circulation, bypassing the liver; esterases then release free testosterone in the periphery. Absorption depends on dietary fat taken with the capsule, which is why serum levels on oral undecanoate are notoriously erratic.
receptor fingerprint
(AR, NR3C4)Testosterone undecanoate is an inactive ester prodrug; after esterase cleavage the released testosterone binds AR and drives androgen-response-element transcription
Intestinal lymphatic transport via chylomicrons (oral formulations only)The long undecanoate side chain makes the molecule lipophilic enough to be absorbed into intestinal lymphatics with dietary fat, bypassing first-pass hepatic metabolism
Hypothalamic-pituitary GnRH/LH/FSH axisNegative feedback suppresses endogenous LH and FSH, shutting down testicular testosterone production and spermatogenesis
5-alpha-reductase type 1 and 2 (SRD5A1, SRD5A2)Converts released testosterone to dihydrotestosterone, a substantially more potent AR agonist
Aromatase (CYP19A1)Converts a fraction of released testosterone to oestradiol
Safetyrisks and cautions, not medical advice
an androgen; this site already refuses the sourcing question for anabolic-androgenic steroids and check-aas-sourcing enforces that refusal
Resources
Don't even think about it.
Research
- 2005first citedNebido: a long-acting injectable testosterone for the treatment of male hypogonadism
- 2021controlled trialTestosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle prog…
- 2025most recentA Randomized Controlled Trial Comparing Testosterone Enanthate and Testosterone Undecanoate as…
- 1.Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial
- 2.A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men
- 3.Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism
- 4.A Randomized Controlled Trial Comparing Testosterone Enanthate and Testosterone Undecanoate as a Gender Affirming Hormonal Therapy in Trans Males
- 5.Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights
- 6.Newer formulations of oral testosterone undecanoate: development and liver side effects
- 7.Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism
7 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
Notes and cautions
- Injectable testosterone undecanoate (Aveed) carries a boxed warning for pulmonary oil microembolism and anaphylaxis and is available in the United States only through a restricted REMS programme requiring 30 minutes of post-injection observation; the large oil volume is the reason.
- The oral formulations carry a separate boxed warning for blood pressure increases, which can raise cardiovascular risk and require blood-pressure monitoring at baseline and periodically.
- All testosterone products carry class warnings for polycythaemia (haematocrit must be checked at baseline, 3 to 6 months and annually, with treatment held above 54%), suppression of spermatogenesis and fertility, worsening of benign prostatic hyperplasia and sleep apnoea, and secondary exposure risk for topical forms.
- Testosterone is a Schedule III controlled substance in the United States with a labelled abuse and dependence warning.